Objectives: Studies have proposed two opposing roles for copper-bound forms of prion protein (PrP) as an anti-oxidant supporting the neuronal functions and as a pro-oxidant leading to neurodegenerative process involving the generation of reactive oxygen species. The aim of this study is to test the hypothesis in which putative copper-binding peptides derived from PrP function as possible catalysts for monoamine-dependent conversion of hydrogen peroxide to superoxide in vitro.
Introduction
Prion protein (PrP) from the brains of animals with transmissible spongiform encephalopathies (TSE) is present as partially protease-resistant form while that in uninfected brains presents as fully sensitive form [1] . In general, the former represents the infectious scrapie isoform of PrP (PrP Sc ) and the latter represents the intrinsic cellular PrP (PrP C ). Such deposition of abnormal protein fibrils is a prominent pathological feature of many different "protein conformational" diseases, including not only "prion" dementias but also some important neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and motor neuron disease [2] . In the cases of β-amyloid which accumulates in the brain in Alzheimer's disease and of α-synuclein accumulating in Lewy bodies in Parkinson's disease, there are good evidences that the toxic mechanism involves the production of reactive oxygen species (ROS) such as H 2 O 2 and hydroxyl radicals (HO · ), supporting the view that one of the fundamental molecular mechanisms underlying the pathogenesis of cell death in neurodegenerative diseases could be the direct production of ROS during formation of the abnormal protein aggregates [2, 3] .
As generalized in Fig. 1 , PrPs from mammals have six to seven putative Cu-binding sites consisted of 4 distinct sequences. Opazo et al. [4] have propounded the importance of metals in neurobiology and proposed two opposing roles for copper-bound PrP as an anti-oxidant required for the neuronal functions and as a pro-oxidant leading to neurodegenerative process. To date, anti-oxidative roles of PrP C are well recognized. It has been shown that E. coli cells expressing PrP sequence (octapeptide repeats region) acquired the resistance to Cu and Cu-dependent oxidative damages, indicating that PrP C possibly contributes to protection of cells from free Cu-catalyzed generation of ROS such as HO · [5] . According to Wong et al. [6] , Cu-bound PrP C shows a superoxide dismutase (SOD)-like activity in vitro, and its expression likely contributes to the cellular response to oxidative damages to the cells. Sauer et al. [7] have shown in tumor spheroids that an increase in ROS stimulates the production of PrP C and other ROS scavenging enzymes such as Cu, Zn-SOD and catalase, while ROS-lowering treatments effectively down-regulate the expression of PrP C , implying that PrP C expression in tumor spheroids is regulated by the internal redox state to meet the requirement to protect the cells from ROS. Interestingly, a drastic depress in SOD-like activity has been shown in the affinity-purified total PrP preparation isolated from scrapie-infected mouse brains suggesting that prion disease results in denature of PrP thus no longer active in ROS removal [6] .
However, contrary to above reports, there are views questioning the proposed SOD-like activity of PrPs. Jones et al. [8] have reported that recombinant PrP exhibits no detectable dismutase activity above baseline levels measured for copper (II) ions.
It is generally accepted that, like amyloid-β peptide, prion induces apoptotic cell death in neuronal tissues [9] . A PrP amino acid sequence 106-126 covering a putative Cu-binding site, likely forms the region causing neuronal apoptosis since a synthetic Cu-bound peptide corresponding to PrP 106-126 is highly fibrillogenic and highly toxic to neuronal cells as if behaving as a PrP Sc mimic [9, 10] . PrPs from mammals and chicken show similar sequences, but human sequence was tested. (4) Well characterized analog for PrP helix 2 sequence was used [33] . The PrP helix 2 sequences varied among species but the Cu-anchoring H residue is highly conserved in various mammals such as mouse, bovine, ovine, tammar wallaby, brush-tailed possum, and Brazilian opossum.
Through in vitro studies with electron spin resonance spectroscopy, Allsop and his colleagues have shown that H 2 O 2 (detected with a spin trap after conversion to HO · via Fenton reaction) is produced during the early stages of protein aggregation associated with neurodegenerative diseases involving β-amyloid, α-synuclein and toxic forms of PrP [11] [12] [13] . Especially Cu-loaded PrP 106-126, the neurotoxic region, likely catalyzes the robust generation of H 2 O 2 [12] .
In addition to the Cu-loaded PrP peptide-dependent formation of H 2 O 2 , the present study reports the production of superoxide anion (O 2
•-), another key member of ROS in biological systems, by Cu-binding PrP fragments in the presence of certain co-factors. Previously, the author has proposed a hypothetical model mechanism in which Cu-bound form of PrP catalyzes the generation of ROS in the presence of some natural co-factors at specific occasions in the neuronal tissues [14] . The author has made a speculation that aromatic monoamines may form a group of such co-factors possibly contributing to the PrP-dependent oxidative burst [14] since Cu-bound PrP has high affinity and catalytic activity for oxidation of some aromatic monoamines such as dopamine which is abundantly present in neuronal tissues [15] . The aim of the present study is to test the hypothesis in which putative Cu-binding peptides derived from PrP function as possible catalysts for monoamine-dependent
Materials and methods

Peptides
Four peptides corresponding to each Cu-binding sequence in PrP protein were synthesized to examine the behavior of such Cu-binding domains in chemiluminescence analysis of peptide-mediated oxidative burst. The peptides were obtained from the custom peptide service department of Sigma Genosis Japan (Ishikari, Hokkaido). The amino acid sequences of the peptides chemically synthesized and purified on high pressure liquid chromatography were (1) PHGGGWGQ (purity, 95.72%), (2) GGGTH (purity, 98.98%), (3) KTNMKHMA (purity, 98.85%) and (4) VNITKQHTVTTTT (purity, 99.02%). Chemicals 2-Methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]py razin-3-one (Cypridina luciferin analog, CLA), a chemiluminescence reagent specific to O 2
•-, was purchased from Tokyo Kasei Kogyo Co. (Tokyo, Japan). Phenylethylamine (PEA), tyramine hydrochloride, and tryptamine hydrochloride were purchased from Wako Pure Chemical Industries Ltd. (Osaka, Japan). Benzylamine, dopamine hydrochloride, and serotonin were from Nakalai Tesque Inc. (Kyoto, Japan). Other chemicals used in this study were of reagent grade purchased from Sigma (St. Louis, MO, USA).
Detection of superoxide
The peptides and other chemicals were dissolved in phosphate buffered saline and generation of O 2
•-was monitored by chemiluminescence of CLA with a CHEM-GLOW Photometer (American Instrument Co., MD., USA) equipped with a pen recorder, and expressed as relative luminescence units (rlu) as previously described [16] . CLA-chemiluminescence specifically indicates the generation of O 2
•-(and 1 O 2 with a lesser extent) but not that of O 3 , H 2 O 2 or HO • [17] . According to our previous study, the signal for 1 O 2 can be minimized by avoiding the use of high concentration of organic solvents such as ethanol over 2% (v/v) in the culture media [18] . Thus the induced chemiluminescence recorded here reflects the generation of O 2
•-rather than 1 O 2 .
Results
Aromatic monoamine-dependent oxidative burst catalyzed by the helical Cu-bound peptide Since earlier studies suggested the high affinity of PrP towards dopamine and related monoamines [15] , direct interactions between PrP-derived peptides and some aromatic monoamines leading to generation of O 2
•-was examined in phosphate buffered saline containing 5 µM CLA, by measuring the O 2
•--specific chemiluminescence. However, we observed no increase in O 2
•--dependent chemiluminescence in the reaction mixture simply consisted of peptides and aromatic monoamines (data not shown). Then, addition of other co-factors such as CuSO 4 •--dependent chemiluminescence was observed ( Fig.  2A) . The observed burst of O 2
•-production was a biphasic event consisting of the acute spike and the gradual increase in O 2
•-. As discussed below, the PEA-induced acute spike can be observed in the Cu-H 2 O 2 solution lacking peptides, only the later phase with gradual large increase in chemiluminescence must be attributed to the helical peptide-dependent reactions. Other peptides except for GGGTH also showed catalytic activity leading to biphasic O 2
•-production with lesser extents. Here again, only the secondary phase of oxidative burst must be considered as the consequences of peptide chemistry. Among the peptides, the activity of VNITKQHTVTTTT peptide sequence was outstanding thus is of great interests.
The cases of tyramine instead of PEA added to the reaction mixture containing 5 μM CLA, 0.3 µM helical peptide, 0.9 µM CuSO 4 , and 1 mM H 2 O 2 are shown in Fig. 2B . Effects of various aromatic amines namely PEA, tyramine, dopamine, serotonin, tryptamine, benzylamine, on generation of O 2
•-in peptide-Cu-H 2 O 2 system were compared (Fig. 2B,   upper inset) . Among the aromatic monoamines, only three monoamines, PEA, tyramine, and benzylamine induced the generation of O 2
•-, and the structures of such active monoamines are shown in Fig. 2C . In addition, effects of two salicylates known to stimulate the conversion of H 2 O 2 to O 2
•-by human methemoglobin [19, 20] and various peroxidases [20] , were also tested (Fig. 2B, upper inset) . However, these salicylates were shown to be poor substrates for the generation of O 2
•-in this system. Interestingly, five related compounds inactive in induction of O 2
•-namely, serotonin, tryptamine, dopamine, salicylate and aspirin were shown to interfere with the PEA-induced O 2
•--generating reaction (Fig. 2B, lower  inset) , opening the ways for chemical and clinical modulation or manipulation of the monoamine-dependent oxidative burst in the PrP rich neuronal tissues.
As the helical peptide was shown to be most active among four Cu-binding peptides derived from PrP as the catalyst for PEA-dependent generation of O 2
•-, three other peptides less active towards PEA were shown to be also poorly active even towards tyramine and benzylamine (data not shown).
Among, three active monoamines, PEA is the most abundant species in neuronal tissues since PEA is a key precursor for many of catecholamine neurotransmitters. It is likely that reaction involving PEA is most likely to occur in the neuronal tissues compared to the reactions involving tyramine or benzylamine, thus following assays were carried out using PEA as a possible substrate.
Requirement for co-factors
In the reaction mixtures lacking either of 5 components namely CLA, helical peptide, Cu, H 2 O 2 and aromatic monoamines, no drastic increase in the second phase of O 2
•--dependent chemiluminescence was observed, suggesting that any component is necessarily required for the reaction leading to generation and detection of O 2
•-. Typical results for peptide-Cu-H 2 O 2 -PEA system are shown (Fig. 3) . Effects of the concentrations of helical peptide (Fig.  3A) , copper (Fig. 3B) [21, 22] or human methemoglobin [19] .
Here, the Cu-loaded peptide-dependent O 2
•-generation was shown to be fueled by H 2 O 2 added to the reaction mixture. Actually, supply of H 2 O 2 at the micro-domains on Cu-bound whole PrP is possible since Cu-loaded PrP 106-126, the neurotoxic region, is known to catalyze the production of H 2 O 2 [12] . Despite of weak O 2 •--generating activity of KTNMKHMA corresponding to the neurotoxic sequence ( Fig. 2A) , this region may contribute to the oxidative burst by producing H 2 O 2 . 
Discussion
Cu-binding sites on PrP
Importance of metalloproteins in neurobiology has been shown both as oxidant and antioxidant in neurodegenerative processes [4] . Cu is an essential trace element but its redox reactivity leads to the risk of damage to the cells and tissues, especially in neurodegenerative diseases such as Menkes' and Wilson's diseases occurring via disorders of Cu metabolism, and Alzheimer's disease and 'prion' diseases, the two major conformational diseases, as documented [23-25, etc] . The likely roles for Cu in induction of critical steps in the apoptotic pathways leading to neurodegeneration is outlined in the above reviews.
Recent studies have shown that PrPs can form a novel group of Cu-binding proteins [26, 27] . Human PrP has four Cu-binding sites in the "octarepeats" region (PrP 60-91) in which amino acid sequence PHGGGWGQ appears four times and each repeat possibly binds single Cu 2+ at physiological neutral and basic range of pH [28] . In general, the most relevant copper binding mode would involve formation of a 4:1 octarepeat:Cu complex involving coordination of one single Cu molecule by the 4 histidines on the 4 octarepeat segments of a single PrP molecule [29] . In chicken, the Cu-binding sites analogous to the octarepeats are known as hexa-repeats with each repeat consisting of the amino acid sequence HNPGYP and here again His residues play a key role in anchoring of Cu [30] . Morante et al. [31] showed that partial occupancy of Cu on bovine PrP is manifested by binding of Cu to PrP in the intermolecular or inter-octarepeat orientations while total occupancy of Cu is manifested by intra-repeat binding of Cu to the octarepeat region.
In vitro studies have shown that the actual least motif in the octarepeats necessarily required for binding of Cu consists of 4 amino acids HGGG [28] or 5 amino acids HGGGW [32] . Although there are additional Cu-binding sites on PrP such as amino acid regions 92-96 (GGGTH) [27] , 124-126 (KHM) [10] and 180-193 (VNITIKQHTVTTTT) [33] , and all studies suggested that His residue in each region (or each repeat unit) plays a key role in anchoring of Cu (Fig. 1) •-. Although the octarepeat-dependent oxidative burst (second phase) was about one forth of the helical peptide-dependent one, this amino acid octet is repeated 4 times in human PrP and 6 times in bovine PrP, its contribution to oxidative burst in whole protein can be greater than that observed for the single repeat peptide.
Redox regulations
The amino-terminal part of PrP (23-98) is rich in amino acid residues susceptible to oxidation, such as His, Lys, Arg, and Pro, thus PrP is sensitive to oxidative changes such as production of ROS and the conformational changes in PrP may be readily induced by redox changes [15, 34] . In addition to the above amino acid residues on PrP, Met residues may be good targets for attacks by ROS. Recently, H 2 O 2 -dependent oxidation of Met residues has been reported for recombinant Syrian hamster PrP (29-231) [35] . The likely target residues include Met 109 , Met 112 , Met 129 and Met 134 and the susceptibility to oxidation of each Met residue was shown to be a function of accessibility to the solvent. While Cu-catalyzed oxidation leads to extensive aggregation of PrP, the H 2 O 2 -dependent Met oxidation on PrP leads only to a modest increase in β-sheet structure.
According to recently proposed model, there may be an intermediate structure of PrP between PrP C and PrP Sc , to be formed from PrP C in response to cellular redox changes thus designated as PrP RDX [36] . An in vitro study demonstrated that PrP RDX of recombinant hamster PrP is catalytically active and capable of further conversion of PrP C to PrP RDX . At the end, PrP RDX accumulates and disulfide bonds are formed among each PrP RDX molecule, and lastly formation of PrP Sc is completed. This attractive model successfully explained how pathogenic form of PrP could be propagated by the presence of an intermediate PrP.
Note that the PrP RDX originally proposed by Lee and Eisenberg [36] was described to be in the oligomeric form distinct from the inert SH swapped dimeric form. Due to the nature of experimental design aimed to produce the redox-activated PrP oligomers at once from the SH-opened PrP monomers produced by exposing the bulk of PrP to the stepwise reduction and oxidation, their model (domain-swapping model) lacks the idea on the very initial event possibly occurring on a single molecule. Here the author wish to mention that PrP-catalyzed generation of O 2 •-(that may attack the SH residues on PrP) as a possible redox step(s) that converts the monomeric native PrP C to the catalytically active monomeric PrP RDX intermediate which in turn acts as the seed for further production of PrP RDX from PrP C , and to elongate the oligomers. The latest report by Shiraishi et al. [37] 
